FdaApplication
ANDA 201272
Identifiers
- fda_app_no: ANDA201272
Properties
| Property | Value |
|---|---|
| applicant_name | PLATINUM PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2018-11-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
3 products